Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
2.
Int. j. morphol ; 37(2): 677-681, June 2019. graf
Article in Spanish | LILACS | ID: biblio-1002275

ABSTRACT

El angiomixoma de la pelvis es un tumor mesenquimal inusual; que dado su alto potencial de recidiva es relevante que la exéresis quirúrgica sea lo más radical posible. Por su parte, la endometriosis infiltrativa profunda, es otra entidad poco frecuente que requiere de tratamientos complejos. La co-existencia de ambas patologías representa una situación absolutamente infrecuente; de los que hay muy pocos casos reportado en la literatura occidental. Se presenta el caso de una mujer de 41 años de edad que desarrolló ambas entidades nosológicas de forma concomitante y que fue tratada quirúrgicamente con buenos resultados.


Angiomyxoma of the pelvis is an unusual mesenchymal tumor; that given its high potential for recurrence, it is relevant that the surgical resection be as radical as possible. For its part, to deep infiltrative endometriosis is another rare entity that requires complex treatments. The co-existence of both pathologies represents an absolutely infrequent situation; of which there are very few cases reported in western literature. We present the case of a 41-year-old woman who developed both clinical entities concomitantly and who was treated surgically with good results.


Subject(s)
Humans , Female , Adult , Pelvic Neoplasms/pathology , Endometriosis/pathology , Myxoma/pathology , Pelvic Neoplasms/surgery , Pelvic Neoplasms/complications , Colectomy , Endometriosis/surgery , Endometriosis/complications , Myxoma/surgery , Myxoma/complications
3.
Rev. bras. cir. cardiovasc ; 34(1): 22-27, Jan.-Feb. 2019. tab, graf
Article in English | LILACS | ID: biblio-985231

ABSTRACT

Abstract Objective: To disclose the relationships between the anatomic features of cardiac myxomas and plasma interleukin (IL)-6 levels. Methods: Twelve patients undergoing cardiac myxoma resection at The First Hospital of Putian, Teaching Hospital, Fujian Medical University were enrolled into this study. Pre- and postoperative IL-6 levels were determined by an enzyme-linked immunosorbent assay method, and correlations between cardiac myxoma dimension or volume and plasma IL-6 levels were analyzed. C-reactive protein (CRP) levels were also evaluated. Results: IL-6 and CRP levels were significantly decreased one month after cardiac myxoma resection in comparison to preoperative values. IL-6 and CRP levels did not differ between patients with a cardiac myxoma of irregular appearance and those with a myxoma of regular gross appearance, or between patients with a pedicled or a sessile myxoma. Decrement of IL-6 of patients with irregular cardiac myxomas was much higher than that of patients with regular ones, while no intergroup difference was noted in decrement of CRP. A close direct correlation was noted between IL-6 levels and maximal dimension (length) or volume of cardiac myxomas, whereas CRP levels only correlated with maximal dimension of cardiac myxomas. Conclusion: Anatomic features of cardiac myxomas (sessile, irregular appearance, maximal dimension, and volume) could be determinants of the patients' circulating IL-6 levels. IL-6 was likely to be a more sensitive biomarker than CRP in predicting the inflammatory status of patients with cardiac myxoma. Sessile and irregular cardiac myxomas might predict more severe inflammatory conditions for their more abundant endothelial cells and IL-6 overproduction.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , C-Reactive Protein/analysis , Interleukin-6/blood , Heart Neoplasms/blood , Myxoma/blood , Postoperative Period , Reference Values , Enzyme-Linked Immunosorbent Assay , Biomarkers, Tumor/blood , Retrospective Studies , Tumor Burden , Preoperative Period , Heart Neoplasms/surgery , Heart Neoplasms/pathology , Myxoma/surgery , Myxoma/pathology
4.
Medicina (B.Aires) ; 78(6): 440-442, Dec. 2018. ilus
Article in Spanish | LILACS | ID: biblio-976143

ABSTRACT

La condición de inmunosuprimido aumenta el riesgo de cáncer en trasplantados renales, en comparación a la población general. La mejor supervivencia de esta población en los últimos años ha convertido a las neoplasias y a la enfermedad cardiovascular en las principales causas de morbi-mortalidad. Presentamos el caso de un paciente trasplantado renal que desarrolló cuatro años después del trasplante una forma inusual de tumor mesenquimatoso, el angiomixoma agresivo, que requirió resección quirúrgica amplia.


The condition of immunosuppressed increases the risk of cancer in kidney transplant patients, as compared to the general population. The best survival of inmunosupressed patients in recent years has turned both neoplasms and cardiovascular diseases into the main causes of morbidity and mortality. We present the case of a renal transplanted patient who developed an unusual form of mesenchymal tumor such as the aggressive angiomyxoma, four years after the implant and requiring wide surgical resection.


Subject(s)
Humans , Male , Adult , Kidney Transplantation/adverse effects , Immunocompetence , Mesenchymoma/etiology , Myxoma/etiology , Magnetic Resonance Spectroscopy , Risk Factors , Immunosuppressive Agents/adverse effects , Mesenchymoma/surgery , Mesenchymoma/pathology , Abdominal Neoplasms/surgery , Abdominal Neoplasms/etiology , Abdominal Neoplasms/pathology , Myxoma/surgery , Myxoma/pathology
6.
Article in Chinese | WPRIM | ID: wpr-941754

ABSTRACT

Aggressive angiomyxoma is a rare mesenchymal tumor. To discuss the clinicopathological characteristics, treatment and prognosis of aggressive angiomyxoma, four cases of aggressive angiomyxoma of soft tissue in abdominopelvic cavity were collected from January 2015 to August 2017 in Peking University International Hospital. The clinical data, imaging examination, histopathological features, immunophenotype, therapy and prognosis were analysed. The related literatures were reviewed. All of the patients were adult females, age range from 27 to 49 years and mean 33 years. The clinical complaint was abdominal distention with no definite predisposing factor, or occasional physical-exam finding with no obvious discomfort. Three cases were primary and one case was recurrent. Typical layered or swirled structural sign was presented by CT and MRI scanning of three cases. All tumors located in the pelvic cavity, and attached to the uterus, vagina, rectum, bladder or ureter. One case was involved in the abdominal cavity simultaneously,adhesive to the spine, inferior vena cava and spleen. The gross appearance of tumors was from 5 to 22 cm in maximum diameter. The sectioned surfaces were soft, solid, white or yellow-gray, focally accompanied by edema, mucoid degeneration or cystic change. Microscopic observation showed that tumor cells were short spindle shaped and little atypical, the stroma was loose like edematous mucus or collagen, and the vessels were rich in thin and thick-wall. Partially the vessel wall expressed hyaline degeneration. Also tumors might infiltrate surrounding tissue, such as fat or nerve. The immunohistochemistry results of all cases were estrogen receptor and progesterone receptor diffusely moderate positive, Desmin and smooth muscle actin mostly positive, whereas CD34 expressed only in vessel and S-100 protein, CD117 and Dog1 all negative. All the tumors were complete surgical excision. During follow-up, one case recurred the second time. Our conclusions are the diagnosis of aggressive angiomyxoma is based on pathological morphology supplemented by immunohistochemistry, and the tumor may relapse after surgical resection.


Subject(s)
Adult , Desmin/analysis , Female , Humans , Immunohistochemistry , Middle Aged , Myxoma/pathology , Neoplasm Recurrence, Local , Receptors, Estrogen/analysis
7.
Rev. bras. cir. cardiovasc ; 32(3): 228-230, May-June 2017. tab, graf
Article in English | LILACS | ID: biblio-897906

ABSTRACT

Abstract The development of left atrial myxoma after coronary artery bypass graft surgery is a rare entity. A 60-year-old man with previous off-pump coronary artery bypass grafting four years ago with patent coronary grafts was diagnosed with left atrial mass. The patient underwent successful resection of the same through minimally invasive right anterolateral thoracotomy. Histopathology of the atrial mass confirmed the diagnosis of atrial myxoma.


Subject(s)
Humans , Male , Middle Aged , Coronary Artery Bypass/adverse effects , Heart Neoplasms/etiology , Heart Neoplasms/pathology , Myxoma/etiology , Myxoma/pathology , Reoperation , Time Factors , Cardiopulmonary Bypass/methods , Tomography Scanners, X-Ray Computed , Treatment Outcome , Sternotomy/methods , Heart Atria/pathology , Heart Neoplasms/surgery , Myxoma/surgery
10.
Rev. méd. Chile ; 144(12): 1617-1620, dic. 2016. ilus
Article in Spanish | LILACS | ID: biblio-845494

ABSTRACT

We report a 23-year-old woman, with three recent exertional syncopes. Transthoracic (TTE) and transesophageal (TEE) echocardiography found a large heterogeneous mass (38 x 35 mm) arising from the posterior mitral annulus, protruding in systole through the left ventricular outflow tract (LVOT). Heart MRI confirmed the echocardiography findings, suggesting a cardiac myxoma. Cardiac surgery accomplished the complete resection of the lesion, confirming a mass arising from the posterior mitral annulus and preserving mitral anatomy and function. Pathology was positive for a myxoma. Uneventful evolution allowed the discharge of the patient at the fifth postoperative day. Control TTE discarded any complication.


Subject(s)
Humans , Female , Young Adult , Syncope/etiology , Heart Neoplasms/complications , Mitral Valve , Myxoma/complications , Echocardiography, Transesophageal , Diagnosis, Differential , Heart Neoplasms/diagnosis , Heart Neoplasms/pathology , Myxoma/diagnosis , Myxoma/pathology
13.
Einstein (Säo Paulo) ; 13(2): 276-278, Apr-Jun/2015. graf
Article in English | LILACS | ID: lil-751428

ABSTRACT

Female patient, 42-years-old, complaining of difficulty in urinating and swelling in the vulvar area for one year. Her gynecological examination showed extensive injury in the vulvar region and the biopsy done was inconclusive. The removal of the lesion was conducted. After the procedure, the patient remains free of recurrence for 15 months. This case highlights the need to consider angiomyxoma in the differential diagnosis for tumors of unknown cause in the vulvar region.


Paciente do gênero feminino, 42 anos, com queixas de dificuldade ao urinar e aumento de volume na região vulvar há 1 ano. Ao exame ginecológico, apresentava extensa lesão na região vulvar. Biópsia da lesão foi inconclusiva. Realizou-se a exérese da lesão. A paciente permanece livre de recorrências há 15 meses. Este caso destaca a necessidade de considerar o angiomixoma no diagnóstico diferencial de massas de causa desconhecida na região vulvar.


Subject(s)
Adult , Female , Humans , Myxoma/pathology , Vulva/pathology , Vulvar Neoplasms/pathology , Biopsy , Diagnosis, Differential , Myxoma/surgery , Stromal Cells/pathology , Tomography, X-Ray Computed , Treatment Outcome , Vulvar Neoplasms/surgery
14.
Acta ortop. mex ; 29(3): 191-195, ilus, tab
Article in Spanish | LILACS | ID: lil-773374

ABSTRACT

El tumor fibromixoma lipoesclerosante óseo (TFMLE) fue descrito inicialmente por Ragsdale en 1986, como una lesión fibroósea polimórfica de hueso con una mezcla de elementos histológicos incluyendo lipoma, fibroxantoma, mixoma, mixofibroma, necrosis grasa, osificación isquémica, áreas de displasia fibrosa y rara vez cartílago o cambios quísticos. La localización más frecuentemente descrita es en la región intertrocantérica del fémur. Es un hallazgo en pacientes asintomáticos o bien estar asociado a fractura. Radiológicamente es una lesión lítica, geográfica, de margen bien definido y habitualmente esclerótico, en algunos casos puede observarse mineralización en el interior de la lesión o un cierto grado de expansión en el contorno. Se ha descrito la estrecha relación del TFMLE con la displasia fibrosa por las características histológicas y la presencia de una mutación Gsα, otra hipótesis de la etiología de la lesión incluye la reacción de la displasia fibrosa a la fatiga por estrés.


The bone liposclerosing myxofibrous tumor (LSMFT) was initially described by Ragsdale in 1986 as a polymorphic fibroosseous bone lesion with a mix of histologic elements that include lipoma, fibroxanthoma, myxoma, myxofibroma, fat necrosis, ischemic ossification, areas of fibrous dysplasia, and infrequent presence of cartilage or cystic changes. The most frequently reported location is the intertrochanteric area of the femur. Radiologically it is a lytic, geographic lesion, with well-defined margins and usually sclerotic. In some cases findings include mineralization inside the lesion or a certain degree of expansion to the contour. The close relationship between LSMFT and fibrous dysplasia has been described based on the histologic characteristics and the presence of the Gsα mutation. Another hypothesis of the etiology of the lesion is the reaction of fibrous dysplasia to stress.


Subject(s)
Aged, 80 and over , Humans , Male , Bone Neoplasms/diagnosis , Femoral Neoplasms/diagnosis , Lipoma/diagnosis , Myxoma/diagnosis , Bone Neoplasms/pathology , Femoral Neoplasms/pathology , Fibroma/diagnosis , Fibroma/pathology , Fibrous Dysplasia of Bone/diagnosis , Fibrous Dysplasia of Bone/pathology , Lipoma/pathology , Myxoma/pathology , Xanthomatosis/diagnosis , Xanthomatosis/pathology
15.
Article in English | IMSEAR | ID: sea-159460

ABSTRACT

Odontogenic myxomas (OMs) are rare, benign, slow-growing tumors that may arise in the maxilla. They are known to have a female predilection and present as a painless mass commonly in the second or third decade of life, comprising 3-6% of all odontogenic tumors. They show a locally aggressive behavior, are radioresistant tumor and hence the need for early recognition and surgical resection. A high rate of recurrence has also been noted owing to its infiltrative pattern of growth and lack of capsule. Clinical and radiological aspects of maxillary OMs are not conclusive hence it is necessary to have a histopathological exam for the final diagnosis. We present a case of OM involving the maxilla in a 51-year-old female patient. The various histopathological differentials are also discussed.


Subject(s)
Female , Humans , Maxilla/pathology , Middle Aged , Myxoma/anatomy & histology , Myxoma/diagnosis , Myxoma/epidemiology , Myxoma/pathology , Odontogenic Tumors/anatomy & histology , Odontogenic Tumors/diagnosis , Odontogenic Tumors/epidemiology , Odontogenic Tumors/pathology
16.
São Paulo; s.n; 2015. [129] p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: biblio-870998

ABSTRACT

Introdução e Objetivo: A doença mixomatosa da valva mitral leva ao comprometimento de sua matriz devido à alteração em sua composição tecidual provocada pelo desequilíbrio na quantidade de ácidos mucopolissacarídeos ou glicosaminoglicanos. Sua etiologia ainda não está totalmente esclarecida, podendo ocorrer em formas familiares com transmissão autossômica dominante de penetrância variável, que pode ser dependente do tempo ou de prováveis fatores ambientais, situações em que a interação de agentes infecciosos necessita de maiores esclarecimentos. O objetivo deste estudo é a análise dos produtos dos patógenos da Chlamydophila pneumoniae, Mycoplasma pneumoniae e Borrelia burgdorferi em segmentos de cúspide retirados da valva mitral com degeneração mixomatosa, comparada ao grupo controle e a relação dos produtos bacterianos com aumento de marcadores inflamatórios (CD20, CD48, CD68) e de metaloproteinase (MMP9) na etiopatogenia da degeneração mixomatosa da valva mitral. Método: Estudo observacional, analítico, tipo caso-controle, que analisou 2 grupos contendo 20 pacientes cada e divididos em grupo 1, composto por fragmentos de tecido valvar mitral com diagnóstico de degeneração mixomatosa extraídos em procedimentos de troca ou plásticas valvares mitrais; e grupo 2, formado por segmentos de valvas mitrais sem valvopatia retirados no serviço de verificação de óbito. Foram realizadas colorações de hematoxilina e eosina e Movat para diagnóstico histológico da degeneração mixomatosa e técnica de imunohistoquímica para detecção de antígenos da Borrelia burgdorferi, Mycoplasma pneumoniae, mediadores inflamatórios (CD20, CD45, CD68) e marcadores de metaloproteinase (MMP9). A presença de antígenos da Chlamydophila pneumonia e foi pesquisada pela técnica de hibridização in situ. A análise quantitativa dos aspectos microscópicos foi realizada com o analisador de imagens Aperio. A pesquisa de elementos bacterianos foi feita através de microscopia eletrônica...


Background: The myxomatous mitral valve disease leads to impairment due to changes in their tissue composition caused by the imbalance in the amount of acid mucopolysaccharides or glycosaminoglycans. Its etiology is not yet fully understood and may occur in familial forms of autosomal dominant trait with variable penetrance that can be time-dependent or probable environmental factors, where the interaction of infectious agents requires further elucidation. The purpose of this study is the analysis of the pathogens products of Chlamydophila pneumoniae, Mycoplasma pneumoniae and Borrelia burgdorferi in removed cusp segments of the mitral valve with myxoid degeneration, compared to the control group and the ratio of bacterial products with increased inflammatory markers (CD20, CD48, CD68) and metalloproteinase (MMP9) in the pathogenesis of myxomatous degeneration of the mitral valve. Method: Observational, analytical, case-control study which analyzed 2 groups of 20 patients each and divided in group 1, consisting of fragments of mitral valve tissue with diagnosis of myxomatous degeneration extracted in replacement procedures or mitral valve repair; group 2, formed by segments of mitral valves without valvolpaty clinial disease removed in the coroner service. Hematoxylin and eosin and Movat stains were done for histological diagnosis of myxoid degeneration and immunohistochemical technique for the detection of Borrelia burgdorferi, Mycoplasma pneumonia antigens, inflammatory mediators (CD20, CD45, CD68) and markers of metalloproteinase (MMP9). The presence of Chlamydophila pneumonia antigens was verified through an in situ hybridization technique. The quantitative analysis of the microscopic aspects was performed with the Aperio image analyzer. The research of bacterial elements was performed by a transmission electron microscopy. Results: In group 1, 14 (70%) patients were male and 6 (30%) were female. The mean age was (51 to 79 years, sd...


Subject(s)
Humans , Adult , Borrelia burgdorferi , Chlamydophila pneumoniae , Mitral Valve , Mitral Valve Insufficiency , Mitral Valve Prolapse , Mycoplasma pneumoniae , Matrix Metalloproteinase 9/metabolism , Myxoma/metabolism , Myxoma/pathology
17.
Rev. bras. ginecol. obstet ; 35(12): 575-582, dez. 2013. ilus
Article in English | LILACS | ID: lil-699983

ABSTRACT

Aggressive angiomyxoma is a rare, slow-growing soft tissue tumor that usually arises in the pelvis and perineal regions of women in reproductive age, with a marked tendency to local recurrence. Because of its rarity, it is often initially misdiagnosed. Surgical resection is the main treatment modality of aggressive angiomyxoma. We describe a case of a vaginal aggressive angiomyxoma in a 47-year-old woman in which the diagnosis was only made after histological examination. The etiology, presentation, diagnosis and management of this rare tumor are outlined. Angiomyxoma of vulva and vagina refers to a rare disease. Pre-operative diagnosis is difficult due to rarity and absence of diagnostic features, but it should be considered in every mass in genital, perianal and pelvic region in a woman in the reproductive age. Thus, these cases should have complete radiological workup before excision, as pre-diagnosis can change the treatment modality and patient prognosis'.


O angiomixoma agressivo é tumor raro de tecidos moles, de lento crescimento e que geralmente ocorre na pelve e nas regiões perineais de mulheres em idade reprodutiva, com forte tendência à recorrência local. Devido à sua raridade, ele é frequentemente mal diagnosticado. A exerese cirúrgica é a modalidade principal para o tratamento do angiomixoma agressivo. Descrevemos aqui um caso de angiomixoma vaginal agressivo em mulher de 47 anos de idade, que foi diagnosticado apenas após exame histológico. Descrevemos também a etiologia e apresentação, bem como o diagnóstico e tratamento desse raro tumor. O angiomixoma da vulva e vagina constitui doença rara. Devido à raridade desse tumor e à ausência de elementos diagnósticos, o diagnóstico pré-operatório é difícil, mas deveria ser considerado na presença de qualquer massa na região genital, perianal e pélvica de mulheres em idade reprodutiva. Portanto, esses casos deveriam ser submetidos a propedêutica radiológica completa antes da exerese, uma vez que um pré-diagnóstico pode modificar a modalidade de tratamento e o prognóstico do paciente.


Subject(s)
Female , Humans , Middle Aged , Myxoma/pathology , Vaginal Neoplasms/pathology
19.
Ann Card Anaesth ; 2013 Oct; 16(4): 293-295
Article in English | IMSEAR | ID: sea-149672

ABSTRACT

A 35‑year-old woman presented with 4 months history of progressively increasing intermittent dyspnea and hemoptysis. Transthoracic echocardiography revealed a loculated mass in the left atrium (LA). A provisional diagnosis of LA myxoma was made. Intraoperatively the tumor was found extending into and closely adherent to the left pulmonary vein and could not be completely cleared off from the pulmonary venous wall. The histopathological examination of the tumor revealed it to be a myxoid malignant fibrous histiocytoma.


Subject(s)
Adult , Echocardiography , Female , Heart Atria/pathology , Heart Neoplasms/pathology , Histiocytoma, Malignant Fibrous , Humans , Myxoma/pathology , Pulmonary Veins/pathology , Vascular Neoplasms/pathology
20.
Arch. cardiol. Méx ; 83(3): 199-208, jul.-sept. 2013. ilus, tab
Article in Spanish | LILACS | ID: lil-703001

ABSTRACT

Los mixomas son los tumores cardiacos primarios más frecuentes, con una incidencia estimada de 0,5-1 por 10(6) individuos por año. Estos tumores han generado interés debido a su peculiar localización (el lado izquierdo del septum auricular cerca de la fossa ovalis), su presentación clínica variable y su histogénesis que aún no ha sido definida. La mayoría de los mixomas cardiacos son esporádicos mientras que aproximadamente el 10% de los casos forman parte del complejo de Carney. Esta neoplasia es de histogénesis incierta, sin embargo, se ha propuesto diferenciación endotelial, neurogénica, fibroblástica, muscular lisa, muscular cardiaca y raramente puede presentar diferenciación glandular. Recientemente, por la expresión de algunos factores específicos cardiomiogénicos, se ha propuesto un origen en células progenitoras mesenquimatosas cardiomiocíticas. Histológicamente los mixomas cardiacos están compuestos por células estelares fusiformes y poligonales inmersas en una matriz mixoide amorfa. Por inmunohistoquímica algunos marcadores endoteliales están presentes como el CD31, CD34 y FVIIIAg. Ha sido también informada positividad a la proteína S-100, calretinina, vimentina, desmina, miosina de músculo liso, CD56, α1-antitripsina, y α1-antiquimiotripsina. La resección quirúrgica es actualmente el único tratamiento. Presentamos en este artículo una revisión histopatológica e inmunohistoquímica de los mixomas cardiacos.


Mixomas are the most common primary cardiac tumors with an estimate incidence of 0,5-1 per 10(6) individuals per year. These tumors have generated interest due to their unique location (left side of the atrial septum near the fossa ovalis), variable clinical presentation and undefined histogenesis. Most cardiac myxomas occur sporadically while approximately 10% of diagnosed cases develop as part of Carney complex. This neoplasm is of uncertain histogenesis, however, endothelial, neurogenic, fibroblastic, and cardiac and smooth muscle cells differentiation has been proposed, and rarely glandular differentiation has been observed. Recently, due to the expression of certain cardiomyocyte-specific factors, an origin of mesenchymal cardiomyocytes progenitor cells has been suggested. Histologically cardiac myxomas are mainly composed of stellated, fusiform and polygonal cells, immersed in an amorphous myxoid matrix. Immunohistochemically some endothelial markers, such as CD31, CD34, FVIIIAg, are present. Positive staining has also been reported for S-100 protein, calretinin, vimentin, desmin, smooth muscle myosin, CD56, α1 antitrypsin and α 1 antichymotrypsin. Surgical resection is currently the only treatment of choice. We present in this article a histopathological and immunohistochemical review of cardiac myxomas.


Subject(s)
Humans , Heart Neoplasms/pathology , Myxoma/pathology , Immunohistochemistry
SELECTION OF CITATIONS
SEARCH DETAIL